We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$65.7B
AUM Growth
+$7.59B
Cap. Flow
-$1.34B
Cap. Flow %
-2.05%
Top 10 Hldgs %
12.37%
Holding
7,215
New
735
Increased
2,740
Reduced
3,074
Closed
505

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$245M
2
KEY icon
KeyCorp
KEY
+$199M
3
RTX icon
RTX Corp
RTX
+$183M
4
EMC
EMC CORPORATION
EMC
+$170M
5
RL icon
Ralph Lauren
RL
+$167M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$245M
2
USB icon
US Bancorp
USB
+$216M
3
AAPL icon
Apple
AAPL
+$207M
4
V icon
Visa
V
+$188M
5
BAC icon
Bank of America
BAC
+$177M

Sector Composition

Rank Sector Weight
1 Financials 9.51%
2 Consumer Discretionary 7.62%
3 Energy 7.06%
4 Technology 6.57%
5 Industrials 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCMP
6826
PUT
DELISTED
CMC Materials, Inc. Common Stock
CCMP
-200
Closed -$7K
AXE
6827
DELISTED
Anixter International Inc
AXE
-1
Closed -$84
CYOU
6828
DELISTED
Changyou.com Limited American Depositary Share
CYOU
-14,886
Closed -$453K
AVEO
6829
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-1,360
Closed -$34K
ARQL
6830
CALL
DELISTED
Arqule Inc
ARQL
-4,200
Closed -$10K
ARQL
6831
DELISTED
Arqule Inc
ARQL
-4,967
Closed -$12K
ARQL
6832
PUT
DELISTED
Arqule Inc
ARQL
-4,500
Closed -$10K
IDXG
6833
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
-144
Closed -$68K
CRZO
6834
DELISTED
Carrizo Oil & Gas Inc
CRZO
-378,998
Closed -$12.6M
RTEC
6835
CALL
DELISTED
Rudolph Technologies Inc
RTEC
-4,000
Closed -$45K
RTEC
6836
DELISTED
Rudolph Technologies Inc
RTEC
-21,603
Closed -$242K
RTEC
6837
PUT
DELISTED
Rudolph Technologies Inc
RTEC
-2,900
Closed -$32K
TOWR
6838
DELISTED
Tower International, Inc.
TOWR
-12,164
Closed -$241K
CRAY
6839
DELISTED
Cray, Inc.
CRAY
-14,664
Closed -$357K
BT
6840
DELISTED
BT Group plc (ADR)
BT
-12,942
Closed -$304K
WAGE
6841
DELISTED
WageWorks, Inc.
WAGE
-332,676
Closed -$11.5M
LXFT
6842
DELISTED
Luxoft Holding, Inc.
LXFT
-99,268
Closed -$1.98M
USG
6843
DELISTED
Usg
USG
-6,228
Closed -$158K
CASM
6844
DELISTED
CAS Medical Systems, Inc.
CASM
-13,522
Closed -$22K
ELLI
6845
DELISTED
Ellie Mae Inc
ELLI
$0 ﹤0.01%
2
-13,513
-100% -$377K
ICON
6846
PUT
DELISTED
Iconix Brand Group, Inc.
ICON
-120
Closed -$35K
DNB
6847
DELISTED
Dun & Bradstreet
DNB
-9,935
Closed -$968K
CVRR
6848
DELISTED
CVR Refining, LP
CVRR
-7,707
Closed -$232K
NAUH
6849
DELISTED
National American University Holdings, Inc.
NAUH
-11,347
Closed -$42K
OCLR
6850
DELISTED
Oclaro Inc.
OCLR
-13,339
Closed -$16K

Similar funds

Ken Griffin's Q3 2013 Portfolio in Review

As of Q3 2013, Ken Griffin held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Ken Griffin's Q3 2013 filing shows 735 new, 2,740 increased, 3,074 reduced and 505 closed positions. Its largest new stake was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M. The largest sale was Pfizer, an estimated $245M.

By sector, the portfolio is most concentrated in Financials at 9.5% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Energy.

  • Ken Griffin's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
  • Ken Griffin added most to Philip Morris in Q3 2013, an estimated $245M increase.
  • Ken Griffin's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
  • Ken Griffin fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
  • Ken Griffin's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
  • Ken Griffin opened 735 new positions and closed 505 in Q3 2013.
  • Ken Griffin's portfolio value rose 13% quarter-over-quarter to $65.7B.

Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.